XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities    
Net income $ 182,456 $ 187,498
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 45,326 44,564
Stock option expense 22,376 19,343
(Benefit)/provision for deferred income taxes (8,232) 10,408
Noncash long-term incentive compensation 6,637 4,343
Litigation settlements 2,050  
Noncash directors' compensation 1,444 1,170
Amortization of debt issuance costs 500 247
Changes in operating assets and liabilities:    
(Increase)/decrease in accounts receivable (27,843) 16,166
Increase in inventories (2,239) (360)
Decrease in prepaid expenses 781 1,257
Decrease in accounts payable and other current liabilities (15,815) (15,765)
Change in current income taxes 12,314 (10,277)
Net change in lease assets and liabilities (892) 313
Increase in other assets (8,622) (42,424)
Increase/(decrease) in other liabilities 11,426 (6,555)
Other sources/(uses) 69 (241)
Net cash provided by operating activities 221,736 209,687
Cash Flows from Investing Activities    
Capital expenditures (45,075) (39,066)
Proceeds from sale of fixed assets 506 2,037
Business combinations, net of cash acquired (3,994) (2,044)
Other uses (409) (841)
Net cash used by investing activities (48,972) (39,914)
Cash Flows from Financing Activities    
Payments on other long-term debt (97,500) (1,250)
Proceeds from other long-term debt   100,000
Proceeds from exercise of stock options 58,277 17,128
Purchases of treasury stock (27,769) (101,539)
Dividends paid (17,446) (16,391)
Change in cash overdrafts payable 16,182 5,535
Capital stock surrendered to pay taxes on stock-based compensation (5,446) (12,497)
Debt issuance costs   (1,584)
Payments on revolving line of credit   (299,400)
Proceeds from revolving line of credit   116,500
Other sources/(uses) (38) (1,389)
Net cash used by financing activities (73,740) (194,887)
Increase/(Decrease) in Cash and Cash Equivalents 99,024 (25,114)
Cash and cash equivalents at beginning of period 74,126 32,895
Cash and cash equivalents at end of period $ 173,150 $ 7,781